References
- Furst DE, Amato AA, Iorga SR, et al. Epidemiology of adult idiopathic inflammatory myopathies in a U.S. managed care plan. Muscle Nerve. 2012;45:676–683.
- Limaye V, Hakendorf P, Woodman RJ, et al. Mortality and its predominant causes in a large cohort of patients with biopsy-determined inflammatory myositis. Intern Med J. 2012;42:191–198.
- Bohan A, Peter J, Bowman R, et al. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore). 1977;56:255–286.
- Malik A, Hayat G, Kalia JS, et al. Idiopathic inflammatory myopathies: clinical approach and management. Front Neurol. 2016;7:64.
- Dalakas MC. Inflammatory muscle diseases. N Engl J Med. 2015;372:1734–1747.
- Pestronk A. Acquired immune and inflammatory myopathies: pathologic classification. Curr Opin Rheumatol. 2011;23:595–604.
- Oldroyd A, Lilleker J, Chinoy H. Idiopathic inflammatory myopathies - a guide to subtypes, diagnostic approach and treatment. Clin Med (Lond). 2017;17:322–328.
- Albrecht I, Wick C, Hallgren A, et al. Development of autoantibodies against muscle-specific FHL1 in severe inflammatory myopathies. J Clin Invest. 2015;125:4612–4624.
- Fiorentino DF, Presby M, Baer AN, et al. PUF60: a prominent new target of the autoimmune response in dermatomyositis and Sjogren’s syndrome. Ann Rheum Dis. 2016;75:1145–1151.
- Gunawardena H, Betteridge ZE, McHugh NJ. Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression. Rheumatology (Oxford). 2009;48:607–612.
- Betteridge Z, Gunawardena H, North J, et al. Anti-synthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) associated with polymyositis and interstitial pneumonia. Rheumatology (Oxford). 2007;46:1005–1008.
- Orlandi M, Barsotti S, Cioffi E, et al. One year in review 2016: idiopathic inflammatory myopathies. Clin Exp Rheumatol. 2016;34:966–974.
- Sato S, Hirakata M, Kuwana M, et al. Clinical characteristics of Japanese patients with anti-PL-7 (anti-threonyl-tRNA synthetase) autoantibodies. Clin Exp Rheumatol. 2005;23:609–615.
- Yamasaki Y, Yamada H, Nozaki T, et al. Unusually high frequency of autoantibodies to PL-7 associated with milder muscle disease in Japanese patients with polymyositis/dermatomyositis. Arthritis Rheum. 2006;54:2004–2009.
- Selva-O’Callaghan A, Labrador-Horrillo M, Solans-Laque R, et al. Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy. Arthritis Rheum. 2006;55:791–798.
- Aussy A, Boyer O, Cordel N. Dermatomyositis and immune-mediated necrotizing myopathies: a window on autoimmunity and cancer. Front Immunol. 2017;8:992.
- Betteridge ZE, Gunawardena H, Chinoy H, et al. Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis. Ann Rheum Dis. 2009;68:1621–1625.
- Sato S, Kuwana M, Fujita T, et al. Anti-CADM-140/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease. Mod Rheumatol. 2013;23:496–502.
- Limaye V, Bundell C, Hollingsworth P, et al. Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase in patients with immune-mediated myositis and necrotizing myopathy. Muscle Nerve. 2015;52:196–203.
- Salajegheh M, Lam T, Greenberg SA. Autoantibodies against a 43 KDa muscle protein in inclusion body myositis. PLoS One. 2011;6:e20266.
- Greenberg SA. Cytoplasmic 5ʹ-nucleotidase autoantibodies in inclusion body myositis: isotypes and diagnostic utility. Muscle Nerve. 2014;50:488–492.
- Brouwer R, Hengstman GJ, Vree Egberts W, et al. Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis. 2001;60:116–123.
- Rigolet A, Musset L, Dubourg O, et al. Inflammatory myopathies with anti-Ku antibodies: a prognosis dependent on associated lung disease. Medicine (Baltimore). 2012;91:95–102.
- Coppo P, Clauvel JP, Bengoufa D, et al. Inflammatory myositis associated with anti-U1-small nuclear ribonucleoprotein antibodies: a subset of myositis associated with a favourable outcome. Rheumatology (Oxford). 2002;41:1040–1046.
- Blijham PJ, Hengstman GJ, Hama-Amin AD, et al. Needle electromyographic findings in 98 patients with myositis. Eur Neurol. 2006;55:183–188.
- Rider LG, Ruperto N, Pistorio A, et al. 2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspects. Rheumatology (Oxford). 2017;56:1884–1893.
- Adams EM, Chow CK, Premkumar A, et al. The idiopathic inflammatory myopathies: spectrum of MR imaging findings. Radiographics. 1995;15:563–574.
- Van De Vlekkert J, Maas M, Hoogendijk JE, et al. Combining MRI and muscle biopsy improves diagnostic accuracy in subacute-onset idiopathic inflammatory myopathy. Muscle Nerve. 2015;51:253–258.
- Fraser DD, Frank JA, Dalakas M, et al. Magnetic resonance imaging in the idiopathic inflammatory myopathies. J Rheumatol. 1991;18:1693–1700.
- Marden FA, Connolly AM, Siegel MJ, et al. Compositional analysis of muscle in boys with Duchenne muscular dystrophy using MR imaging. Skeletal Radiol. 2005;34:140–148.
- Park J, Olsen N, King L Jr., et al. Use of magnetic resonance imaging and P-31 magnetic resonance spectroscopy to detect and quantify muscle dysfunction in the amyopathic and myopathic variants of dermatomyositis. Arthritis Rheum. 1995;38:68–77.
- McCullough MB, Domire ZJ, Reed AM, et al. Evaluation of muscles affected by myositis using magnetic resonance elastography. Muscle Nerve. 2011;43:585–590.
- Chakouch MK, Charleux F, Bensamoun SF. Quantifying the elastic property of nine thigh muscles using magnetic resonance elastography. PLoS One. 2015;10:e0138873.
- Selva-O’Callaghan A, Grau JM, Gamez-Cenzano C, et al. Conventional cancer screening versus PET/CT in dermatomyositis/polymyositis. Am J Med. 2010;123:558–562.
- Li Y, Zhou Y, Wang Q. Multiple values of (18)F-FDG PET/CT in idiopathic inflammatory myopathy. Clin Rheumatol. 2017;36:2297–2305.
- Pillen S, Arts IM, Zwarts MJ. Muscle ultrasound in neuromuscular disorders. Muscle Nerve. 2008;37:679–693.
- Pillen S, Boon A, Van Alfen N. Muscle ultrasound. Handb Clin Neurol. 2016;136:843–853.
- Napier N, Shortt C, Eustace S. Muscle edema: classification, mechanisms, and interpretation. Semin Musculoskelet Radiol. 2006;10:258–267.
- Tomasova Studynkova J, Charvat F, Jarosova K, et al. The role of MRI in the assessment of polymyositis and dermatomyositis. Rheumatology (Oxford). 2007;46:1174–1179.
- Del Grande F, Santini F, Herzka DA, et al. Fat-suppression techniques for 3-T MR imaging of the musculoskeletal system. Radiographics. 2014;34:217–233.
- Kuo GP, Carrino JA. Skeletal muscle imaging and inflammatory myopathies. Curr Opin Rheumatol. 2007;19:530–535.
- Murphy WA, Totty WG, Carroll JE. MRI of normal and pathologic skeletal muscle. AJR Am J Roentgenol. 1986;146:565–574.
- Kumar Y, Wadhwa V, Phillips L, et al. MR imaging of skeletal muscle signal alterations: systematic approach to evaluation. Eur J Radiol. 2016;85:922–935.
- Filli L, Maurer B, Manoliu A, et al. Whole-body MRI in adult inflammatory myopathies: do we need imaging of the trunk? Eur Radiol. 2015;25:3499–3507.
- Gulani V, Calamante F, Shellock FG, et al. International society for magnetic resonance in M. Gadolinium deposition in the brain: summary of evidence and recommendations. Lancet Neurol. 2017;16:564–570.
- Sookhoo S, Mackinnon I, Bushby K, et al. MRI for the demonstration of subclinical muscle involvement in muscular dystrophy. Clin Radiol. 2007;62:160–165.
- Dion E, Cherin P, Payan C, et al. Magnetic resonance imaging criteria for distinguishing between inclusion body myositis and polymyositis. J Rheumatol. 2002;29:1897–1906.
- Cox FM, Reijnierse M, van Rijswijk CS, et al. Magnetic resonance imaging of skeletal muscles in sporadic inclusion body myositis. Rheumatology (Oxford). 2011;50:1153–1161.
- Degardin A, Morillon D, Lacour A, et al. Morphologic imaging in muscular dystrophies and inflammatory myopathies. Skeletal Radiol. 2010;39:1219–1227.
- Bossuyt PM, Irwig L, Craig J, et al. Comparative accuracy: assessing new tests against existing diagnostic pathways. BMJ. 2006;332:1089–1092.
- May DA, Good RB, Smith DK, et al. MR imaging of musculoskeletal tumors and tumor mimickers with intravenous gadolinium: experience with 242 patients. Skeletal Radiol. 1997;26:2–15.
- Swash M, Brown MM, Thakkar C. CT muscle imaging and the clinical assessment of neuromuscular disease. Muscle Nerve. 1995;18:708–714.
- Bai X, Tie N, Wang X, et al. Intense muscle activity due to polymyositis incidentally detected in a patient evaluated for possible malignancy by FDG PET/CT imaging. Clin Nucl Med. 2017;42:647–648.
- Jackson RS, Schlarman TC, Hubble WL, et al. Prevalence and patterns of physiologic muscle uptake detected with whole-body 18F-FDG PET. J Nucl Med Technol. 2006;34:29–33.
- Basu S, Alavi A. Unparalleled contribution of 18F-FDG PET to medicine over 3 decades. J Nucl Med. 2008;49:17N–21N,37N.
- Morita Y, Kuwagata S, Kato N, et al. 18F-FDG PET/CT useful for the early detection of rapidly progressive fatal interstitial lung disease in dermatomyositis. Intern Med. 2012;51:1613–1618.
- Sun L, Dong Y, Zhang N, et al. [(18)F]Fluorodeoxyglucose positron emission tomography/computed tomography for diagnosing polymyositis/dermatomyositis. Exp Ther Med. 2018;15:5023–5028.
- Tanaka S, Ikeda K, Uchiyama K, et al. [18F]FDG uptake in proximal muscles assessed by PET/CT reflects both global and local muscular inflammation and provides useful information in the management of patients with polymyositis/dermatomyositis. Rheumatology (Oxford). 2013;52:1271–1278.
- Tateyama M, Fujihara K, Misu T, et al. Clinical values of FDG PET in polymyositis and dermatomyositis syndromes: imaging of skeletal muscle inflammation. BMJ Open. 2015;5:e006763.
- Newman JS, Adler RS, Bude RO, et al. Detection of soft-tissue hyperemia: value of power Doppler sonography. AJR Am J Roentgenol. 1994;163:385–389.
- Najm A, Orr C, Gallagher L, et al. Knee joint synovitis: study of correlations and diagnostic performances of ultrasonography compared with histopathology. RMD Open. 2018;4:e000616.
- Heckmatt JZ, Leeman S, Dubowitz V. Ultrasound imaging in the diagnosis of muscle disease. J Pediatr. 1982;101:656–660.
- Hall MM. Return to play after thigh muscle injury: utility of serial ultrasound in guiding clinical progression. Curr Sports Med Rep. 2018;17:296–301.
- Pillen S, van Alfen N. Skeletal muscle ultrasound. Neurol Res. 2011;33:1016–1024.
- Reeves ND, Maganaris CN, Narici MV. Ultrasonographic assessment of human skeletal muscle size. Eur J Appl Physiol. 2004;91:116–118.
- Reimers CD, Fleckenstein JL, Witt TN, et al. Muscular ultrasound in idiopathic inflammatory myopathies of adults. J Neurol Sci. 1993;116:82–92.
- Fischer AQ, Carpenter DW, Hartlage PL, et al. Muscle imaging in neuromuscular disease using computerized real-time sonography. Muscle Nerve. 1988;11:270–275.
- Noto Y, Shiga K, Tsuji Y, et al. Contrasting echogenicity in flexor digitorum profundus-flexor carpi ulnaris: a diagnostic ultrasound pattern in sporadic inclusion body myositis. Muscle Nerve. 2014;49:745–748.
- Yoshida K, Ito H, Furuya K, et al. Angiogenesis and VEGF-expressing cells are identified predominantly in the fascia rather than in the muscle during the early phase of dermatomyositis. Arthritis Res Ther. 2017;19:272.
- Reimers CD, Finkenstaedt M. Muscle imaging in inflammatory myopathies. Curr Opin Rheumatol. 1997;9:475–485.
- Collison CH, Sinal SH, Jorizzo JL, et al. Juvenile dermatomyositis and polymyositis: a follow-up study of long-term sequelae. South Med J. 1998;91:17–22.
- Meng C, Adler R, Peterson M, et al. Combined use of power Doppler and gray-scale sonography: a new technique for the assessment of inflammatory myopathy. J Rheumatol. 2001;28:1271–1282.
- Kim HJ, Lee HK, Cho JH, et al. Quantitative comparison of transient elastography (TE), shear wave elastography (SWE) and liver biopsy results of patients with chronic liver disease. J Phys Ther Sci. 2015;27:2465–2468.
- Berg WA, Mendelson EB, Cosgrove DO, et al. Quantitative maximum shear-wave stiffness of breast masses as a predictor of histopathologic severity. AJR Am J Roentgenol. 2015;205:448–455.
- Garra BS. Elastography: current status, future prospects, and making it work for you. Ultrasound Q. 2011;27:177–186.
- Lam AC, Pang SW, Ahuja AT, et al. The influence of precompression on elasticity of thyroid nodules estimated by ultrasound shear wave elastography. Eur Radiol. 2016;26:2845–2852.
- Creze M, Nordez A, Soubeyrand M, et al. Shear wave sonoelastography of skeletal muscle: basic principles, biomechanical concepts, clinical applications, and future perspectives. Skeletal Radiol. 2018;47:457–471.
- Bamber J, Cosgrove D, Dietrich CF, et al. EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 1: basic principles and technology. Ultraschall Med. 2013;34:169–184.
- Heizelmann A, Tasdemir S, Schmidberger J, et al. Measurements of the trapezius and erector spinae muscles using virtual touch imaging quantification ultrasound-Elastography: a cross section study. BMC Musculoskelet Disord. 2017;18:370.
- Shin HJ, Kim MJ, Kim HY, et al. Comparison of shear wave velocities on ultrasound elastography between different machines, transducers, and acquisition depths: a phantom study. Eur Radiol. 2016;26:3361–3367.
- Eby SF, Cloud BA, Brandenburg JE, et al. Shear wave elastography of passive skeletal muscle stiffness: influences of sex and age throughout adulthood. Clin Biomech (Bristol, Avon). 2015;30:22–27.
- Alfuraih AM, O’Connor P, Hensor E, et al. The effect of unit, depth, and probe load on the reliability of muscle shear wave elastography: variables affecting reliability of SWE. J Clin Ultrasound. 2018;46:108–115.
- Dubois G, Kheireddine W, Vergari C, et al. Reliable protocol for shear wave elastography of lower limb muscles at rest and during passive stretching. Ultrasound Med Biol. 2015;41:2284–2291.
- Song Y, Lee S, Yoo DH, et al. Strain sonoelastography of inflammatory myopathies: comparison with clinical examination, magnetic resonance imaging and pathologic findings. Br J Radiol. 2016;89:20160283.
- Botar-Jid C, Damian L, Dudea SM, et al. The contribution of ultrasonography and sonoelastography in assessment of myositis. Med Ultrason. 2010;12:120–126.
- Muthupillai R, Lomas DJ, Rossman PJ, et al. Magnetic resonance elastography by direct visualization of propagating acoustic strain waves. Science. 1995;269:1854–1857.
- Lodi R, Taylor DJ, Tabrizi SJ, et al. Normal in vivo skeletal muscle oxidative metabolism in sporadic inclusion body myositis assessed by 31P-magnetic resonance spectroscopy. Brain. 1998;121:2119–2126.
- Argov Z, Taivassalo T, De Stefano N, et al. Intracellular phosphates in inclusion body myositis–a 31P magnetic resonance spectroscopy study. Muscle Nerve. 1998;21:1523–1525.
- Cea G, Bendahan D, Manners D, et al. Reduced oxidative phosphorylation and proton efflux suggest reduced capillary blood supply in skeletal muscle of patients with dermatomyositis and polymyositis: a quantitative 31P-magnetic resonance spectroscopy and MRI study. Brain. 2002;125:1635–1645.